Study of Intraparenchymal Therapy as Adjunct Therapy in Patients With Recurrent, Resectable Glioblastoma Multiforme.
Clinical trial NCT02433392 · TERMINATED
Trial details
- NCT number
- NCT02433392
- Sponsor
- Boston Scientific Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2015-07-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.